Circulating IL-10 Levels in Carotid Artery Disease

1. Jonasson, L., Holm, J., Skalli, O., Bondjers, G., & Hansson, G. K. (1986). Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis, Thrombosis, and Vascular Biology, 6(2), 131-138. doi:10.1161/01.atv.6.2.13110.1161/01.atv.6.2.1312937395Open DOISearch in Google Scholar

2. Epstein, F. H., & Ross, R. (1999). Atherosclerosis — An Inflammatory Disease. New England Journal of Medicine, 340(2), 115-126. doi:10.1056/nejm19990114340020710.1056/NEJM1999011434002079887164Open DOISearch in Google Scholar

3. Libby, P., Lichtman, A., & Hansson, G. (2013). Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans. Immunity, 38(6), 1092-1104. doi:10.1016/j.immuni.2013.06.00910.1016/j.immuni.2013.06.009376450023809160Search in Google Scholar

4. Tuomisto, K., Jousilahti, P., Sundvall, J., Pajunen, P., & Salomaa, V. (2006). C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thrombosis and Haemostasis. doi:10.1160/th05-08-057110.1160/TH05-08-057116525580Open DOISearch in Google Scholar

5. Breland, U. M., Michelsen, A. E., Skjelland, M., Folkersen, L., Krohg-Sørensen, K., Russell, D., Ueland, T., Yndestad, A., Paulsson-Berne, G., Damås, J.K., Oie, E., Hansson, G.K., Halvorsen, B., & Aukrust, P. (2010). Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovascular Research, 86(2), 265-273. doi:10.1093/cvr/cvq0442013911510.1093/cvr/cvq04420139115Search in Google Scholar

6. Martin-Ventura, J. L., Madrigal-Matute, J., Munoz- Garcia, B., Blanco-Colio, L. M., Oostrom, M. V., Zalba, G., Fortuño, A., Gomez-Guerrero, C., Ortega, L., Ortiy, A., Diey, J., & Egido, J. (2009). Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells. Cardiovascular Research, 83(3), 586-594. doi:10.1093/cvr/cvp14110.1093/cvr/cvp14119423618Open DOISearch in Google Scholar

7. Szodoray, P., Timar, O., Veres, K., Der, H., Szomjak, E., Lakos, G., Aleksza, M., Nakken, B., Szegedi, G. & Soltesz, P. (2006). Th1/Th2 Imbalance, Measured by Circulating and Intracytoplasmic Inflammatory Cytokines – Immunological Alterations in Acute Coronary Syndrome and Stable Coronary Artery Disease. Scandinavian Journal of Immunology, 64(3), 336-344. doi:10.1111/j.1365-3083.2006.01816.x10.1111/j.1365-3083.2006.01816.x16918703Open DOISearch in Google Scholar

8. Yamagami, H. (2005). Associations of Serum IL-18 Levels With Carotid Intima-Media Thickness. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(7), 1458-1462. doi:10.1161/01.atv.0000168417.52486.5610.1161/01.ATV.0000168417.52486.5615860738Search in Google Scholar

9. Elkind, M. S., Rundek, T., Sciacca, R. R., Ramas, R., Chen, H., Boden-Albala, B., Rabbani, L., Sacco, R. L. (2005). Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis, 180(1), 181-187. doi:10.1016/j.atherosclerosis.2004.11.01510.1016/j.atherosclerosis.2004.11.01515823291Open DOISearch in Google Scholar

10. Heeschen, C. (2003). Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes. Circulation, 107(16), 2109-2114. doi:10.1161/01.cir.0000065232.57371.2510.1161/01.CIR.0000065232.57371.2512668510Search in Google Scholar

11. Silveira, A., McLeod, O., Strawbridge, R. J., Gertow, K., Sennblad, B., Baldassarre, D., et al. (2015). Plasma IL-5 concentration and subclinical carotid atherosclerosis. Atherosclerosis, 239(1), 125–130. doi.org/10.1016/j.atherosclerosis.2014.12.04610.1016/j.atherosclerosis.2014.12.046Open DOISearch in Google Scholar

12. Fiorentino, D. F. Bond MW, & Mosmann TB. (1989). Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. Journal of Experimental Medicine, 170(6), 2081-2095. doi:10.1084/jem.170.6.208110.1084/jem.170.6.2081Open DOISearch in Google Scholar

13. Malefyt, R. D. (1991). Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine, 174(5), 1209-1220. doi:10.1084/jem.174.5.120910.1084/jem.174.5.1209Search in Google Scholar

14. Mosser, D. M., & Zhang, X. (2008). Interleukin-10: new perspectives on an old cytokine. Immunological Reviews, 226(1), 205-218. doi:10.1111/j.1600-065x.2008.00706.x10.1111/j.1600-065X.2008.00706.xSearch in Google Scholar

15. Pestka, S., Krause, C.D., Sarkar, D., Walter, M.R., Shi, Y. & Fisher, P.B. (2004) Interleukin-10 and Related Cytokines and Receptors. Annual Review of Immunology, 22, 929-979.10.1146/annurev.immunol.22.012703.104622Search in Google Scholar

16. Akdis, C. A. Joss A., Akdis M., Faith A. & Blaser K. A. (2000). A molecular basis for T cell suppression by IL- 10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. The FASEB Journal. doi:10.1096/fj.99-0874fje10.1096/fj.99-0874fjeSearch in Google Scholar

17. Opp, M., Smith, E., & Hughes, T. (1995). Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. Journal of Neuroimmunology, 60(1-2), 165-168. doi:10.1016/0165-5728(95)00066-b10.1016/0165-5728(95)00066-BSearch in Google Scholar

18. Ma, X., Aste-Amezaga, M., Gri, G., Gerosa, F., & Trinchieri, G. (1997). Immunomodulatory Functions and Molecular Regulation of IL-12. Chemical Immunology and Allergy IL-12, 1-22. doi:10.1159/00005868710.1159/000058687Open DOISearch in Google Scholar

19. Varma, T. K., Toliver-Kinsky, T. E., Lin, C. Y., Koutrouvelis, A. P., Nichols, J. E., & Sherwood, E. R. (2001). Cellular Mechanisms That Cause Suppressed Gamma Interferon Secretion in Endotoxin-Tolerant Mice. Infection and Immunity, 69(9), 5249-5263. doi:10.1128/iai.69.9.5249-5263.200110.1128/IAI.69.9.5249-5263.2001Open DOISearch in Google Scholar

20. Mocellin, S. Panelli M.C., Wang E., Nagorsen D. & Marincola F.M. (2003). The dual role of IL-10. Trends in Immunology, 24(1), 36-43. doi:10.1016/s1471-4906(02)00009-110.1016/S1471-4906(02)00009-1Search in Google Scholar

21. Sikka, G., Miller, K. L., Steppan, J., Pandey, D., Jung, S. M., Fraser, C. D., et al. (2013). Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age. Experimental Gerontology, 48(2), 128-135. doi:10.1016/j.exger.2012.11.00110.1016/j.exger.2012.11.001374417823159957Search in Google Scholar

22. Pinderski, L. J. (2002). Overexpression of Interleukin- 10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor-Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes. Circulation Research, 90(10), 1064-1071. doi:10.1161/01.res.0000018941.10726.fa10.1161/01.RES.0000018941.10726.FA12039795Search in Google Scholar

23. Caligiuri, G., Rudling, M., Ollivier, V., Jacob, M.-P., Michel, J.-B., Hansson, G. K., & Nicoletti, A. (2003). Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice. Molecular Medicine, 9(1-2), 10–17.10.1007/BF03402102Search in Google Scholar

24. Han, X., Kitamoto, S., Wang, H., & Boisvert, W. A. (2010). Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice. The FASEB Journal, 24(8), 2869-2880. doi:10.1096/fj.09-14815510.1096/fj.09-148155290928320354139Search in Google Scholar

25. Yoshioka, T., Okada, T., Maeda, Y., Ikeda, U., Shimpo, M., Nomoto, T. et al. (2004). Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice. Gene Therapy, 11(24), 1772-1779. doi:10.1038/sj.gt.330234810.1038/sj.gt.330234815496963Search in Google Scholar

26. Bancroft JD & Gamble M. (2002). Theory and practice of histological techniques. 5Thedition. Churchill Livingstone, Edeinburgh, London, New York, Oxford.Search in Google Scholar

27. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W. Jr, Rosenfeld M.E., Schwartz C.J., Wagner W.D. & Wissler R.W. (1995). A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis. A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation; 92: 1355-1374.Search in Google Scholar

28. Moreno, P. R. (2010). Vulnerable Plaque: Definition, Diagnosis, and Treatment. Cardiology Clinics, 28(1), 1-30. doi:10.1016/j.ccl.2009.09.0081996204710.1016/j.ccl.2009.09.00819962047Search in Google Scholar

29. Shindo, A., Tanemura, H., Yata, K., Hamada, K., Shibata, M., Umeda, Y. et al. Tomimoto, H. (2014). Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability. PLoS ONE, 9(6). doi:10.1371/journal.pone.010004510.1371/journal.pone.0100045406103924936646Open DOISearch in Google Scholar

30. Radosavljevic, G., Ljujic, B., Jovanovic, I., Srzentic, Z., Pavlovic, S., Zdravkovic, N., Milovanovic, M., Bankovic, D., Knezevic, M., Acimovic, LJ., & Arsenijevic, N. (2010). Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma, 57(2), 135-144. doi:10.4149/neo_2010_02_13510.4149/neo_2010_02_13520099977Open DOISearch in Google Scholar

31. Zhu, Y., Yang, H., Diao, Z., Li, Y., & Yan, C. (2015). Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study. Molecular Neurobiology, 53(4), 2698-2704. doi:10.1007/s12035-015-9368-y10.1007/s12035-015-9368-y26253723Search in Google Scholar

32. Ambrosius, W., Kazmierski, R., Michalak, S., & Kozubski, W. (2006). Anti-inflammatory cytokines in subclinical carotid atherosclerosis. Neurology, 66(12), 1946-1948. doi:10.1212/01.wnl.0000219808.28678.4810.1212/01.wnl.0000219808.28678.4816801669Open DOISearch in Google Scholar

33. Puz, P., & Lasek–Bal, A. (2017). Repeated measurements of serum concentrations of TNF-alpha, interleukin- 6 and interleukin-10 in the evaluation of internal carotid artery stenosis progression. Atherosclerosis, 263, 97-103. doi:10.1016/j.atherosclerosis.2017.06.00810.1016/j.atherosclerosis.2017.06.008Search in Google Scholar

34. Verma, S. K., Garikipati, V. N., Krishnamurthy, P., Khan, M., Thorne, T., Qin, G., Losordo, D. W. & Kishore, R. (2016). IL-10 Accelerates Re-Endothelialization and Inhibits Post-Injury Intimal Hyperplasia following Carotid Artery Denudation. Plos One, 11(1). doi:10.1371/journal.pone.014761510.1371/journal.pone.0147615Search in Google Scholar

35. Halvorsen, B., Wæhre, T., Scholz, H., Clausen, O. P., Thüsen, J. H., Müller, F., Heimli, H., Tonstad, S., Hall, C., Frøland, S.S., Biessen, E.A., Damås, J.K. & Aukrust, P. (2004). Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms. Journal of Lipid Research, 46(2), 211-219. doi:10.1194/jlr.m400324-jlr20010.1194/jlr.M400324-JLR200Search in Google Scholar

36. Björkerud, S., & Björkerud, B. (1996). Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. The American Journal of Pathology, 149(2), 367–380.Search in Google Scholar

37. Davies, M. J. (1996). Stability and Instability: Two Faces of Coronary Atherosclerosis: The Paul Dudley White Lecture 1995. Circulation, 94(8), 2013-2020. doi:10.1161/01.cir.94.8.201310.1161/01.CIR.94.8.2013Search in Google Scholar

38. Libby, P. (1995). Molecular Bases of the Acute Coronary Syndromes. Circulation, 91(11), 2844-2850. doi:10.1161/01.cir.91.11.284410.1161/01.cir.91.11.2844Open DOISearch in Google Scholar

39. Han, X., & Boisvert, W. A. (2014). Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thrombosis and Haemostasis, 113(3), 505-512. doi:10.1160/th14-06-050910.1160/TH14-06-0509Search in Google Scholar

40. Chau, L., Lee, T., Yen, H., & Pan, C. (1998). Role of interleukin-12 in development of atherosclerosis in apoe-deficient mice. Atherosclerosis, 136. doi:10.1016/s0021-9150(97)84555-810.1016/S0021-9150(97)84555-8Open DOISearch in Google Scholar

41. Tits, L. V., Stienstra, R., Lent, P. V., Netea, M., Joosten, L., & Stalenhoef, A. (2011). Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Krüppel-like factor 2. Atherosclerosis, 214(2), 345-349. doi:10.1016/j.atherosclerosis.2010.11.01810.1016/j.atherosclerosis.2010.11.01821167486Open DOISearch in Google Scholar

42. Du, L., Dronadula, N., Tanaka, S., & Dichek, D. A. (2011). Helper-Dependent Adenoviral Vector Achieves Prolonged, Stable Expression of Interleukin-10 in Rabbit Carotid Arteries but Does Not Limit Early Atherogenesis. Human Gene Therapy, 22(8), 959-968. doi:10.1089/hum.2010.17521198399Search in Google Scholar

43. Kosmala, W., Derzhko, R., Przewlocka-Kosmala, M., Orda, A., & Mazurek, W. (2008). Plasma levels of TNF-α, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coronary Artery Disease, 19(6), 375-382. doi:10.1097/mca.0b013e3282fc617c10.1097/MCA.0b013e3282fc617c18955829Search in Google Scholar

44. Zhang, D.-F., Song, X.-T., Chen, Y.-D., Yuan, F., Xu, F., Zhang, M., Zhang, M.-D., Wang, W., Dai, J & Lyu, S.- Z. (2016). Prognostic performance of interleukin-10 in patients with chest pain and mild to moderate coronary artery lesions—an 8-year follow-up study. Journal of Geriatric Cardiology : JGC, 13(3), 244–251. doi. org/10.11909/j.issn.1671-5411.2016.03.012Search in Google Scholar

45. Fang, L., Moore, X.-L., Dart, A. M., & Wang, L.-M. (2015). Systemic inflammatory response following acute myocardial infarction. Journal of Geriatric Cardiology : JGC, 12(3), 305–312. doi.org/10.11909/j.issn.1671-5411.2015.03.02010.11909/j.issn.1671-5411.2015.03.020446017526089856Open DOISearch in Google Scholar

46. Kozinski, M., Krzewina-Kowalska, A., Kubica, J., Żbikowska-Gotz, M., Dymek, G., Piasecki, R., Sukiennik, A., Grzesk, G., Bogdan, M., Chojnicki, M., Dziedziczko, A. & Sypniewska, G. (2005). Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis – comparison with stable and unstable angina. Inflammation Research, 54(5), 187-193. doi:10.1007/s00011-005-1342-010.1007/s00011-005-1342-015953990Open DOISearch in Google Scholar

47. Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., et al. (1999). Protective Role of Interleukin-10 in Atherosclerosis. Circulation Research, 85(8). doi:10.1161/01.res.85.8.e1710.1161/01.RES.85.8.e17Search in Google Scholar

48. Kimura T., Tse K., McArdle S., Gerhardt T., Miller J., Mikulski Z., Sidney J., Sette A., Wolf D., & Ley K. (2017)-Atheroprotective vaccination with MHC-II-re- -stricted ApoB peptides induces peritoneal IL-10-pro- -ducing CD4 T cells. Am J Physiol Heart Circ Physiol. Apr 1;312(4):H781-H790. doi: 10.1152/ajpheart.00798.- 2016. Epub 2017 Jan 13. PubMed PMID:28087520; PubMed Central PMCID: PMC5407161.Search in Google Scholar